Will CAR T-cell therapy be used in patients with other than DLBCL types of NHL?

L: english

During SOHO 2019 in Houston, US, the Lymphoma Hub asked Dr David G. Maloney from Fred Hutchinson Cancer Research Center, Seattle, US, about his opinion on whether CAR T-cell therapy will be used in patients with non-Hodgkin lymphoma (NHL), other than DLBCL. He discusses its benefits in patients with follicular lymphoma, MCL, and CLL.

Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF
Was this article informative? Thank you for your feedback!
100% of people found this article informative